KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Other financing activities (2018 - 2019)

Moderna (MRNA) has disclosed Other financing activities for 2 consecutive years, with -$3.7 million as the latest value for Q4 2019.

  • On a quarterly basis, Other financing activities fell 137.2% to -$3.7 million in Q4 2019 year-over-year; TTM through Sep 2019 was $13.6 million, a N/A change, with the full-year FY2025 number at $22.0 million, changed N/A from a year prior.
  • Other financing activities was -$3.7 million for Q4 2019 at Moderna, down from $3.7 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $9.9 million in Q4 2018 to a low of -$3.7 million in Q4 2019.